Helga Zoega

In 2017–2018, Zoega was a Visiting Professorial Fellow at UNSW Sydney, where she was awarded a Scientia Program Award to further her research in Pharmacoepidemiology (2018-2026).

Zoega has served on several scientific and ethical committees, including the Icelandic Science and Technology Policy Council & Icelandic Science Board (2016–19), appointed by the Prime Minister of Iceland. She played a pivotal role in the founding of the Nordic Pharmaco-Epidemiological Network (NorPEN), for which she served on the Executive Committee (2013–18).

Zoega joined the Faculty of Medicine, Centre of Public Health Sciences at the University of Iceland in 2012 and was promoted to Professor in 2016. Previously, she was as a project manager for the Icelandic Prescription Medicines Register at the Directorate of Health (2006-2008).

Zoega was the first to receive a doctorate in Public Health Sciences from the University of Iceland. She defended her PhD thesis in 2011 on psychotropic medication use among children and the effect of ADHD treatment on academic progress. Zoega was a postdoctoral fellow in Epidemiology at the Icahn School of Medicine at Mount Sinai in New York, 2011–2013.

Zoega completed her BA in Political Science at the University of Iceland in 2002. In 2006, she completed an MA in Quantitative Methods in the Social Sciences at Columbia University.

Helga Zoega (born 1976) is a Professor of Public Health at the Faculty of Medicine, University of Iceland. She is a Scientia A/Professor of Pharmacoepidemiology at the Faculty of Medicine and Health, University of New South Wales (UNSW) Sydney, Australia. Her research focuses on the use and safety of medication among vulnerable populations, e.g. pregnant women and children.

Helga Zoega (b. 1976) divides her time between Sydney and Reykjavik. She has daughter and a son.